Curetis GmbH

medical devices

+49 703 14919510

About

Curetis GmbH is a molecular diagnostics company based in Holzgerlingen, Germany, founded in 2007. The company focuses on developing and commercializing rapid and cost-effective syndromic testing solutions for diagnosing severe infectious diseases, particularly in hospitalized patients. Its flagship product, the Unyvero diagnostic platform, allows for quick multi-parameter detection of pathogens and antibiotic resistance markers, significantly reducing the time needed for diagnosis. Curetis offers broad diagnostic panels for various clinical syndromes, including hospitalized pneumonia, blood culture infections, implant and tissue infections, intra-abdominal infections, and urinary tract infections. The company manufactures all its products in Germany and has established international distribution agreements across Europe, the Middle East, and Asia. In 2017, Curetis founded Ares Genetics GmbH in Vienna, Austria, which focuses on next-generation diagnostics and therapeutics. In 2020, Curetis was acquired by OpGen, Inc., enhancing its capabilities in molecular diagnostics and bioinformatics for infectious diseases.

Technologies

Outlook Wix Mobile Friendly Varnish Android

Keywords

molecular diagnostics medical devices antibiotic resistances infectious diseases pathogens pneumonia implant & tissue infections bloodstream infections intraabdominal infections nextgeneration sequencing syndromic testing antimicrobial resistance resistance marker severe urinary tract infections hospitalized infections amr lower respiratory infections biotechnology life sciences medical equipment manufacturing implant infection diagnosis b2b sample to result sample liquefaction dna isolation syndromic testing platform pcr multiplexing microfluidic pcr chambers diagnostic accuracy improvement diagnostic workflow

Location

42 Max-Eyth-Strasse, Holzgerlingen, Baden-Wuerttemberg, Germany, 71088

Related Companies

Companies in the same industry